Safety and efficacy of retromuscular-onlay dual-mesh reconstruction for massive abdominal wall defects secondary to abdominal wall endometriosis resection - Scorecard - MDSpire

Safety and efficacy of retromuscular-onlay dual-mesh reconstruction for massive abdominal wall defects secondary to abdominal wall endometriosis resection

  • By

  • Dongbing Ding

  • Yuan Wang

  • Han Wang

  • Rongpu Liang

  • Jiarong You

  • Qingjian Ye

  • Bo Wei

  • May 13, 2026

  • 0 min

Share

Clinical Scorecard: Evaluation of the Safety and Effectiveness of Retromuscular-Onlay Dual-Mesh Repair for Significant Abdominal Wall Defects Following Resection of Abdominal Wall Endometriosis

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationFemale patients aged 18-50 with significant abdominal wall defects post-AWE resection.
Care Setting

Key Highlights

  • average_length_of_stay

Guideline-Based Recommendations

Diagnosis

  • Histologically confirm AWE through preoperative assessment including symptoms, physical examination, and imaging (e.g., ultrasound, MRI).

Management

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Standardized dual-mesh approach is safe and effective for reconstructing abdominal wall defects, with potential for reduced recurrence rates.

        Clinical Best Practices

        • Utilize component separation technique (CST) for optimal anatomical restoration, supported by recent studies.

        Related Resources & Content

        Original Source(s)

        Safety and efficacy of retromuscular-onlay dual-mesh reconstruction for massive abdominal wall defects secondary to abdominal wall endometriosis resection

        • by Dongbing Ding, Yuan Wang, Han Wang, Rongpu Liang, Jiarong You, Qingjian Ye, Bo Wei

        • May 13, 2026

        Related Content

        31 Live Births Reported Following Uterus Transplant

        Single-center series details maternal, obstetric, and neonatal outcomes among recipients with uterine-factor infertility

        7 Days Noninferior in Bacteremia

        BALANCE compared 7 vs 14 days of treatment among hospitalized patients with bloodstream infections.

        FOXC1 Duplications Linked to Early-Onset Glaucoma

        FOXC1 duplications were the second most common monogenic finding among genetically solved juvenile open-angle glaucoma cases in one registry, supporting the use of copy-number variant analysis in early-onset glaucoma testing.